Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 4Completed 3

Sponsor Class

OTHER 389INDUSTRY 139NIH 66NETWORK 37OTHER_GOV 5UNKNOWN 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 1Small Cell Lung Carcinoma 1Colorectal Neoplasms 1

Interventions

S 1 (combination) 7Cisplatin 7Radiotherapy, Intensity-Modulated 5Paclitaxel 5Oxaliplatin 3Irinotecan 3Capecitabine 3titanium silicide 2raltitrexed 2nimotuzumab 2nabiximols 2Radiotherapy 2Radiation Dose Hypofractionation 2pegylated granulocyte colony-stimulating factor 1nedaplatin 1icaritin 1gimeracil 1anlotinib 1Trastuzumab 1Temozolomide 1Tegafur 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Pemetrexed 1Ondansetron 1Methylene Blue 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × UNKNOWN × Irinotecan × Clear all
NCT04247984 2022-03-11

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

ChineseAMS

Phase 2 Completed
264 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01444521 2014-05-06

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

ChineseAMS

Phase 2 Completed
50 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡